FogPharma

1 follower

‌

FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered “undruggable.” The company’s cell-penetrating miniproteins (CPMPs) combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules. This... Read more

Industries

Biotechnology, Pharmaceutical

Headquarters

Cambridge, United States

Employees

Links

Org chart

Advisor & CEO Designate

CMO & EVP, Clinical & Translational Sciences

VP, Head of People

VP, De Novo Discovery

Thomas Kotarako

SVP, Finance

Chief People Officer

Principal Data Engineer

Amanda Garofalo

Senior Director Clinical Operations

Head Of Facility

Senior Administrative Business Partner

Teams

Research and Development Scientists

13 members

Leadership Team

3 members

Clinical and Translational Operations

6 members

Finance and Accounting

4 members

Similar companies

Adverum Biotech

8 followers

SpringWorks Therapeutics

5 followers

Owkin

4 followers

Empower Pharmacy

4 followers

Stemline Therapeutics

3 followers

Precigen

3 followers

Tenaya Therapeutics

2 followers

Arcutis Biotherapeutics

2 followers

FirstWord Group

2 followers

AbbVie

181 followers

Crinetics Pharmaceuticals

1 follower

Explore companies